Ixekizumab

Oral Glucocorticoids for Psoriasis? The Expert Weighs In
Glucocorticoids
by Allison Sit on
Dermatologists are prescribing oral glucocorticoids for psoriasis despite awareness of risks of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). A recent survey of dermatologists published in the Journal of Drugs in Dermatology found 18% of respondents occasionally prescribe oral glucocorticoids to patients with psoriasis, typically 1-5% of the time. Those wh …
JDD Issue Highlights | April 2022
psoriasis
by NEXT STEPS IN DERM TEAM on
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
Interleukin-17 Inhibitors Therapeutic Cheat Sheet
Interleukin-17
by Angelo Landriscina, MD on
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients.  In this installment of our Therapeutic Cheat Sheet series, we’ll cover everything you need to know to start and monitor your patients on IL-17 blocking therapies. [caption id="attachment_8301" align="alignleft" width="612"] Click image to en …